Transgenic mouse comprising a disruption in an RGS9 gene
US6750375B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2001 |
| Grant date | Jun 15, 2004 |
| Priority date | — |
| Expiry date | Dec 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0362
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to an animal model for studying behavior related to RGS9 and RGS9 modulated dopamine D2-mediated behavior. The invention provides transgenic non-human animals in which RGS9 expression is disrupted, methods of using such animals, and methods of modulating dopamine D2-mediated behavior.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.